Form 4: Director Reeve B. Waud Increases Acadia Healthcare Stake

Director Reeve B. Waud acquired 15,907 shares of Acadia Healthcare common stock through equity grants and a retainer election.

Summary

• Director Reeve B. Waud acquired 6,331 shares of common stock as an equity grant, vesting over three years starting May 6, 2027.
• Director Reeve B. Waud acquired 9,576 shares of common stock in lieu of his 2026 annual cash director retainer.
• Following these transactions, the director holds 75,859 shares directly and maintains indirect beneficial ownership of 653,015 shares through various family trusts and entities.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral-to-positive event, as it reflects standard director compensation and increased insider alignment without indicating any material change in company strategy.

Positives

• Director demonstrates alignment with shareholder interests by electing to receive his annual retainer in company stock.
• Increased direct equity ownership by the director signals confidence in the company's long-term trajectory.

Negatives

• None identified.

Risks

• The director's indirect ownership involves complex trust structures, which may complicate future reporting or divestment activities.

Future Outlook

The filing does not provide forward-looking operational guidance, focusing solely on director equity compensation and ownership changes.

Management Comments

• The director elected to receive his 2026 annual cash retainer in the form of common stock.

Industry Context

StockSavvy.ai notes that director equity-based compensation is a standard governance practice in the healthcare sector, intended to align board incentives with long-term shareholder value creation.

Comparison to Industry Standards

• The practice of directors taking retainers in stock is consistent with governance standards at large-cap healthcare firms like HCA Healthcare and Universal Health Services.
• The three-year vesting schedule for equity grants is standard practice for board compensation to ensure retention and long-term commitment.

Corporate Governance

Related Party Transactions

• Disclosure of indirect ownership through Halcyon Trust, Waud Capital Partners, L.L.C., and various family trusts.

Stakeholder Impact

• Shareholders benefit from increased alignment between the board and company performance.

Next Steps

• Vesting of 6,331 shares beginning May 6, 2027.

Key Dates

Keywords

Acadia Healthcare, ACHC, Insider Trading, Director Compensation, Equity Ownership, Form 4